Last updated 2026-07-23
Total raised
—
Last: Undisclosed Round 2025-04
Stage
Seed
Founded
2018
Headcount
6
HQ
Raanana, Israel
Sector
Health Tech & Life Sciences
About
NeuroTrigger develops a wearable and lightweight muscle re-education system composed of a rechargeable stimulator and a pre-gelled Y-shaped electrode. This system delivers electrical pulses to muscles, facilitating and improving muscle performance, maintaining or increasing range of motion, and preventing or retarding disuse atrophy. The device is controlled by a mobile phone application via Bluetooth, allowing users, caregivers, or technicians to monitor and adjust stimulation parameters. The company has received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB) for general indications and is planning further clinical trials for specific claims like eyelid closure.
Headcount over time
6 employees (2026-09) · 1 point
Offices
Raanana, Israel · HQ / main office
Q&A
- What is NeuroTrigger's primary business?
- NeuroTrigger develops a wearable muscle re-education stimulator system designed to improve or facilitate muscle performance, maintain or increase range of motion, and prevent disuse atrophy.
- When was NeuroTrigger founded?
- NeuroTrigger was founded in June 2018.
- How many employees does NeuroTrigger currently have?
- NeuroTrigger has 1-10 employees.
- What is NeuroTrigger's total funding to date?
- NeuroTrigger has raised a total of $4,120,000 USD.
- When was NeuroTrigger's most recent funding round and what was the amount?
- NeuroTrigger's most recent funding round occurred in April 2025, raising $520,000 USD.
- Which investors participated in NeuroTrigger's July 2023 funding rounds?
- In July 2023, NeuroTrigger received funding from Merage Institute and a grant from BIRD Foundation.
- What regulatory approval has NeuroTrigger received for its product?
- NeuroTrigger has received FDA approval for its non-invasive muscle stimulation system (NTB).
- Who are the co-founders of NeuroTrigger?
- The co-founders of NeuroTrigger are Shachar Paz (Co-founder & CTO), Michal Marks (Co-founder & General Counsel), and Assaf Deutsch (Co-founder & VP R&D).
Team · 15
Michal Marks
Founder · Co-Founder, COO
Dr. Assaf Deutsch
Founder · Co-Founder, R&D Director
Shachar Paz
Founder · Co-Founder
Dr. Hagit Deutsch
Founder · Co-Founder
Nikolai Kunicher
CEO
Prof. Eyal Gur
Medical Director
James V. Mazzo
Director
Shalom Auerbach
Director
Dr. Barak Azmon
Director
Prof. Anat Loewenstein
Advisory Board
Dr. Julie Schallhorn
Advisory Board
Dr. Babak Azizzadeh
Advisory Board
Dr. Marjan Farid
Advisory Board
Dr. Kenneth A Beckman
Advisory Board
Deepinder Kaur Dhaliwal
Advisory Board
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2C
Highlights
1 PatentsVerified
Tags
neuro-stimulationpatientsmedical-deviceswearablemedical-technologieswearablenon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nt-med.com/ |
|---|---|
| linkedin.com/company/69221549 | |
| facebook.com/neuro.trigger.7 |
Identifiers & details
| Legal name | NeuroTrigger Ltd. |
|---|---|
| Founded | 2018-6 |
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | nt-med.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515860047 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-06-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | תמר 3 אבן יהודה |